Skip to content

CHC-blog-logo

Alzheimer’s Research UK

We are constantly on the look-out for inspirational, standout communication campaigns.

Over the last 18 months, and especially in 2016, Alzheimer’s Research UK has really made people sit up and listen. We want to take a moment to praise their fantastic work and examine why they have been so effective. Read more

Giant bacteria, electric shocks and dusty medicinal discoveries – all in a day’s work for CHC

The CHC offices are full of people who have a real passion for science, so it’s important to us that we maintain our curiosity and stay informed. That’s why the CHC team found themselves faced with a 28ft giant inflatable E.coli as we ventured along to two days of New Scientist Live, taking place at the ExCel London.

The hall was split into four themed zones: Technology, Brain & Body, Cosmos and Earth, with each section hosting a number of exhibits and talks. Some of our highlights included:

The future of healthcare –Ruth McKernan of Innovate UK

Read more

Building Collaboration. Inspiring Confidence. Delivering Change.

This year marks five years since CHC’s inception – presenting us with the great opportunity to look back on our remarkable growth as an agency. From our humble beginnings as a small group of consultants working from our homes or coffee shops in 2011, we have continued to build our client base and hire talented people, necessitating not one, but two office moves over the past 12 months. A lot of our growth has come from client recommendations, and for the second year running we were delighted to see in our recent client survey that all of our client contacts would recommend us to a colleague.

This tells us we must be doing something right.

Read more

Patient-Pharma interactions; a mutually beneficial relationship?

Patient-Pharma interactions are vital for drug development, but are often seen in a negative light. There will always be sceptics; those who think pharma companies have cynical intentions when approaching patients, and conversely, those who feel some patients advocate for the wrong motives. However, in recent years patient advocacy has become a pivotal aspect of the drug development process, where pharma companies have increasingly sought the unique insight that patients can offer.

So can there be a healthy and mutually beneficial relationship between patients and pharmaceutical companies? Read more